With over two decades of experience in the pharmaceutical industry, Sharoni Billik founded SBHC in 2016 with a vision to revolutionize strategic KOL engagement for global biopharmaceutical clients.

 

SBHC specializes in a wide array of services including advisory boards, investigator meetings, partnering meetings, consensus-building (Delphi-panel) meetings, publication planning, KOL engagement, and congress planning across clinical development, medical affairs, and commercial sectors.

 

Sharoni is known for her ability to craft customized solutions tailored to each client's unique needs, with a keen focus on efficiency and dedication to streamlined processes.

 

Prior to launching SBHC, Sharoni held pivotal roles in renowned organizations such as Avant Healthcare, Avita Medical, Campbell Alliance (Inventiv Health/Syneos Health), and The PolyPeptide Group, where she honed her expertise in account management, investor relations, regional marketing, and client relations.

 

Sharoni holds a Bachelor of Science in Physiology & Neuroscience from the University of California San Diego (UCSD), a Masters of Bioscience from the Keck Graduate Institute (Claremont Colleges), and an MBA from the Peter F. Drucker Graduate School of Management.

 

Passionate about collaborating with small- and medium sized biopharmaceutical companies, Sharoni specializes in guiding them through early to late phase 2, assisting in strategic planning with investigators and KOLs.

 

In recognition of her outstanding contributions, Sharoni was honored as the Best Medical Affairs Professional Service Provider in California by Global Health & Pharma in 2019.